Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

Matched clinical trials

  • Study on the Use of SB11 Pre-Filled Syringe for Patients with Wet Age-Related Macular Degeneration, Macular Edema from Retinal Vein Occlusion, or Myopic Choroidal Neovascularization

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    Poland
  • Study Comparing EYP-1901 and Aflibercept for Patients with Wet Age-Related Macular Degeneration

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    Czechia Germany Hungary Poland Slovakia
  • Study on Aflibercept for Adults with Diabetic Macular Edema or Wet Age-Related Macular Degeneration

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    Czechia Hungary Slovakia
  • Study of OPT-302 and Aflibercept for Patients with Wet Age-related Macular Degeneration

    Not recruiting

    3 1 1
    Austria Bulgaria Croatia Czechia Estonia France +10
  • Study on the Effectiveness of OPT-302 and Ranibizumab for Patients with Wet Age-related Macular Degeneration

    Not recruiting

    3 1 1 1
    Czechia Denmark France Germany Greece Hungary +4
  • Study of Aflibercept 8mg for Patients with Neovascular Age-Related Macular Degeneration Previously Treated with Faricimab and Aflibercept 2mg

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    Austria
  • Study on Faricimab and Aflibercept for Patients with Neovascular Age-Related Macular Degeneration Receiving Frequent Aflibercept Treatment

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    Austria
  • Study on the Effects of RGX-314 Gene Therapy Compared to Aflibercept and Ranibizumab for Patients with Neovascular Age-Related Macular Degeneration

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    France Germany Hungary Italy Spain
  • Study Comparing RBS-001 and Aflibercept for Patients with Neovascular Age-Related Macular Degeneration

    Not recruiting

    3 1 1 1
    Bulgaria Croatia Poland Slovakia
  • Study of BP05 and Ranibizumab Efficacy and Safety in Patients with Wet Age-Related Macular Degeneration

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    Latvia Slovakia